» Articles » PMID: 27916206

How Many Oocytes Are Optimal To achieve Multiple Live Births With one Stimulation Cycle? The one-and-done Approach

Overview
Journal Fertil Steril
Date 2016 Dec 6
PMID 27916206
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study how many infertility patients would complete an average-sized family (achieve ≥2 live births) after a single, complete in vitro fertilization (IVF) cycle.

Design: A retrospective cohort study.

Setting: University-affiliated private infertility practice.

Patient(s): Women undergoing IVF.

Intervention(s): None.

Main Outcome Measure(s): The outcome of 1 or ≥2 live births after a single retrieval cycle, followed by use of all embryos in subsequent frozen cycles in relation to oocyte number.

Result(s): The pregnancy rate was statistically significantly higher when ≥15 oocytes were retrieved (289 of 699, 41.3%) than <15 oocytes (518 of 1,419, 36.5%). When investigating the outcome of ≥2 live births and assuming that all remaining frozen embryos were used, we found that 498 of 2,226 (22.4%) patients would achieve ≥2 live births. We performed multivariate analysis, and the area under the receiver operating characteristic curve for the model was 0.802. When controlling for multiple factors we found that as the number of oocytes retrieved increased, the chance of at least two live births increased, with odds ratio 1.08 (8% live birth increase per additional oocyte).

Conclusion(s): We demonstrate that one fresh cycle with high oocyte yield is an optimal way to plan IVF treatment. With modern cryopreservation methods, the concept of "one-and-done" could safely achieve ≥2 live births with just one stimulation cycle in almost a quarter of our patients.

Citing Articles

Optimal aspiration pressure of suction pump for oocyte retrieval in infertile patients undergoing in vitro fertilization.

Kim S, Yun Kim H, Han J, Kim H, Ku S PLoS One. 2025; 20(1):e0317812.

PMID: 39869608 PMC: 11771860. DOI: 10.1371/journal.pone.0317812.


Cost-Effectiveness and Clinical Outcomes of Controlled Ovarian Stimulation With Follitropin Delta and Follitropin Alfa: A Retrospective Study.

Kobanawa M, Iwami N, Hanaoka M, Enatsu K, Ichiyama T Cureus. 2025; 16(12):e76371.

PMID: 39867102 PMC: 11759662. DOI: 10.7759/cureus.76371.


Development and validation of a gonadotropin dose selection model for optimized ovarian stimulation in IVF/ICSI: an individual participant data meta-analysis.

Schouten N, Wang R, Torrance H, Van Tilborg T, Bastu E, Bergh C Hum Reprod Update. 2024; 31(2):116-132.

PMID: 39707165 PMC: 11879166. DOI: 10.1093/humupd/dmae032.


ICSI and PGT-A in PCOS phenotype-D patients: a matched case-control study versus idiopathic infertile women.

Vaiarelli A, Cimadomo D, Rucci C, Innocenti F, Taggi M, Pittana E J Assist Reprod Genet. 2024; 41(12):3423-3432.

PMID: 39495342 PMC: 11707217. DOI: 10.1007/s10815-024-03299-z.


Oocyte Competence, Embryological Outcomes and miRNA Signature of Different Sized Follicles from Poor Responder Patients.

Yague-Serrano R, Palomar A, Quinonero A, Gomez V, de Los Santos M, Vidal C Int J Mol Sci. 2024; 25(19).

PMID: 39408572 PMC: 11476082. DOI: 10.3390/ijms251910237.